HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Re: everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial.

AuthorsM Pilar Laguna
JournalThe Journal of urology (J Urol) Vol. 191 Issue 3 Pg. 626-7 (Mar 2014) ISSN: 1527-3792 [Electronic] United States
PMID24522027 (Publication Type: Journal Article, Comment)
Chemical References
  • Antineoplastic Agents
  • Sirolimus
Topics
  • Angiomyolipoma (drug therapy)
  • Antineoplastic Agents (therapeutic use)
  • Female
  • Humans
  • Male
  • Sirolimus (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: